Your browser doesn't support javascript.
loading
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.
Liu, Jun; Budylowski, Patrick; Samson, Reuben; Griffin, Bryan D; Babuadze, Giorgi; Rathod, Bhavisha; Colwill, Karen; Abioye, Jumai A; Schwartz, Jordan A; Law, Ryan; Yip, Lily; Ahn, Sang Kyun; Chau, Serena; Naghibosadat, Maedeh; Arita, Yuko; Hu, Queenie; Yue, Feng Yun; Banerjee, Arinjay; Hardy, W Rod; Mossman, Karen; Mubareka, Samira; Kozak, Robert A; Pollanen, Michael S; Martin Orozco, Natalia; Gingras, Anne-Claude; Marcusson, Eric G; Ostrowski, Mario A.
Affiliation
  • Liu J; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Budylowski P; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Samson R; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Griffin BD; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Babuadze G; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
  • Rathod B; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Colwill K; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Abioye JA; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
  • Schwartz JA; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
  • Law R; Providence Therapeutics Holdings Inc., Calgary, AB, Canada.
  • Yip L; Providence Therapeutics Holdings Inc., Calgary, AB, Canada.
  • Ahn SK; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Chau S; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Naghibosadat M; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Arita Y; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Hu Q; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Yue FY; Providence Therapeutics Holdings Inc., Calgary, AB, Canada.
  • Banerjee A; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
  • Hardy WR; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Mossman K; Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada.
  • Mubareka S; Department of Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK, Canada.
  • Kozak RA; Department of Biology, University of Waterloo, Waterloo, ON, Canada.
  • Pollanen MS; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
  • Martin Orozco N; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Gingras AC; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Marcusson EG; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada.
  • Ostrowski MA; Sunnybrook Research Institute, Toronto, ON, Canada.
Sci Adv ; 8(3): eabj9815, 2022 Jan 21.
Article in En | MEDLINE | ID: mdl-35044832
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / MRNA Vaccines Type of study: Clinical_trials Limits: Animals / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Sci Adv Year: 2022 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / MRNA Vaccines Type of study: Clinical_trials Limits: Animals / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Sci Adv Year: 2022 Type: Article Affiliation country: Canada